Third-Party Partners Needed To Assess Health Tech Algorithms, Califf Says

FDA will likely need to develop partnerships with multiple external entities to keep up with the amount of continuous monitoring of outcomes that will be needed to assess algorithmic artificial intelligence technology in health care, FDA Commissioner Robert Califf said. The commissioner was interviewed about digital health technology at the Consumer Technology Association’s CES Conference in Las Vegas Wednesday (Jan. 10) by Lisa Dwyer, an attorney with the law firm King & Spalding and a former FDA official. Califf said...